Immunogenicity of Membrane-Bound Gangliosides in Viable Whole-Cell Vaccines
- 1 January 1997
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 15 (5) , 491-499
- https://doi.org/10.3109/07357909709047588
Abstract
(1997). Immunogenicity of Membrane-Bound Gangliosides in Viable Whole-Cell Vaccines. Cancer Investigation: Vol. 15, No. 5, pp. 491-499.Keywords
This publication has 46 references indexed in Scilit:
- Prostaglandins and Gangliosides of Tumor Microenvironment: Their Role in AngiogenesisActa Oncologica, 1995
- Attachment of Monophosphoryl Lipid A (MPL) to Cells and Liposomes Augments Antibody Response to Membrane-bound GangliosidesJournal of Autoimmunity, 1994
- Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated gangliosideCellular and Molecular Life Sciences, 1994
- Ganglioside GM3:GD3 ratio as an index for the management of melanomaCancer, 1991
- Ganglioside Composition in Human MeningiomasJournal of Neurochemistry, 1989
- Gangliosides of normal and neoplastic human melanocytesBiochemical and Biophysical Research Communications, 1984
- Gangliosides of human acute leukemia cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983
- Alteration of gangliosides in plasma and red cells of humans bearing melanoma tumorsBiochemical and Biophysical Research Communications, 1978
- VCN-Releasable sialic acid and gangliosides in human neuroblastomasJournal of Pediatric Surgery, 1977
- Glycolipid antigen and its antibodyImmunochemistry, 1968